Stent Firm Biosensors Moves Into China Private Equity Fold
This article was originally published in The Gray Sheet
Singapore interventional cardiology company Biosensors International has agreed to be bought by Beijing-based CITIC, China’s largest state-owned investment group.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.